Astrana Health ACOs Generate $120.4M in Shared Savings, Validating Value-Based Model
ASTH has more than doubled off its 52-week low of $18.08.
Summary
Astrana Health's eight ACOs delivered $120.4 million in gross shared savings for the 2024 performance year, with all achieving net savings. This follows the 8-K filed earlier today and provides market validation of the company's value-based care model at scale, serving nearly 100,000 Medicare beneficiaries. The strong performance, including a top-10 ranking for one ACO, reinforces the earnings momentum seen in Q1 2026 and supports the revenue growth trajectory. The news highlights the company's ability to generate tangible savings in government programs, a key driver for future profitability.
At the time of this announcement, ASTH was trading at $46.87 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $18.08 to $51.60. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.